Home > Search: raloxifene

• Search Results

Search Results Get Your Free Credit Report Right Now! Zip Code: Join our discussion forums! Providers join our directory! General Topics A-Z Conditions Treatments Medications Fitness Nutrition Anatomy Travel/Destinations Other Topics From the West From the East

Main Topic Area Raloxifene All Topic Areas 1 - 2 of 2 Raloxifene Evista Articles 1 - 1 of 1 Study of Tamoxifen and Raloxifene (STAR): Q&A Key Points The Study of Tamoxifen and Raloxifene (STAR) is a clinical trial designed to see how the drug raloxifene (Evista®) compares with the drug tamoxifen (Nolvadex®) in reducing the incidence of breast cancer in women who are at an increased risk for developing the disease (see Question 1). The study is closed to new participants. Results are expected in the summer of 2006 (see Question 1). Women at increased risk for developing breast cancer, who had gone through menopause, and were at... News 1 - 5 of 43  more >> Raloxifene Reduces Breast Cancer Risk In Postmenopausal Women At All Risk Levels MedicalNewsToday - Sat, 16 Sep 2006 08:00 EST Raloxifene Reduces Breast Cancer Risk In Postmenopausal Women At All Risk Levels MedicalNewsToday - Sat, 16 Sep 2006 07:00 EST Raloxifene Reduces Breast Cancer Risk In Postmenopausal Women At All Risk Levels ScienceDaily - Wed, 13 Sep 2006 03:00 EST Raloxifene Helps Reduce Breast Cancer Risk, Raises Risk Of Blood Clot, Stroke, Study Says MedicalNewsToday - Mon, 17 Jul 2006 12:00 EST Raloxifene Doesn't Raise Heart Disease Risk MedicineNet - Thu, 13 Jul 2006 06:00 EST Clinical Trials 1 - 5 of 33  more >> Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer ClinicalTrials.gov Identifier: NCT00003906 - Active, not recruiting Breast Cancer Exemestane and Raloxifene in Treating Postmenopausal Women With a History of Ductal Carcinoma in Situ, Stage I, Stage II, or Stage III Breast Cancer ClinicalTrials.gov Identifier: NCT00004247 - Active, not recruiting Breast Cancer; breast cancer in situ Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis ClinicalTrials.gov Identifier: NCT00383422 - Active, not recruiting Postmenopausal Osteoporosis Study Evaluating TSE-424/Placebo/Raloxifene in Preventing Osteoporosis in Postmenopausal Women ClinicalTrials.gov Identifier: NCT00481169 - Active, not recruiting Osteoporosis AFTER: Altering Fat Through Estrogen and Raloxifene ClinicalTrials.gov Identifier: NCT00149604 - Completed Postmenopause

GoldBambooTM Your Integrative Health and Wellness Resource December 5, 2009

email this page   |    print this page   |    bookmark this page   |    feedback on this page Page Updated: January 17, 2009

Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.